CITI, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 3.255
EU - Europa 1.981
AS - Asia 549
AF - Africa 82
Continente sconosciuto - Info sul continente non disponibili 9
SA - Sud America 5
OC - Oceania 2
Totale 5.883
Nazione #
US - Stati Uniti d'America 3.190
IT - Italia 1.016
SE - Svezia 364
CN - Cina 262
BG - Bulgaria 164
DE - Germania 156
VN - Vietnam 96
SG - Singapore 91
AT - Austria 72
CA - Canada 65
CI - Costa d'Avorio 56
GB - Regno Unito 52
FR - Francia 43
IN - India 29
TR - Turchia 25
HK - Hong Kong 21
FI - Finlandia 19
PL - Polonia 19
BE - Belgio 15
RU - Federazione Russa 15
SN - Senegal 15
EU - Europa 9
GR - Grecia 9
NG - Nigeria 9
NL - Olanda 8
UA - Ucraina 8
CH - Svizzera 6
JP - Giappone 5
KR - Corea 5
TW - Taiwan 4
UZ - Uzbekistan 4
CZ - Repubblica Ceca 3
ES - Italia 3
BR - Brasile 2
CL - Cile 2
RO - Romania 2
AU - Australia 1
AZ - Azerbaigian 1
BY - Bielorussia 1
CY - Cipro 1
DK - Danimarca 1
HU - Ungheria 1
ID - Indonesia 1
IQ - Iraq 1
IR - Iran 1
KE - Kenya 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MK - Macedonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
UG - Uganda 1
VE - Venezuela 1
Totale 5.883
Città #
Fairfield 457
Serra 383
Woodbridge 351
Chandler 310
Ashburn 275
Houston 252
Seattle 205
Ann Arbor 197
Wilmington 166
Sofia 164
Cambridge 128
Beijing 125
Milan 99
New York 87
Princeton 79
Vienna 68
Lawrence 66
Ottawa 57
Abidjan 56
Medford 55
Pisa 55
Florence 46
Dong Ket 42
Frankfurt am Main 41
Des Moines 38
Nanjing 30
Rome 29
London 27
Marseille 22
Dearborn 20
Warsaw 19
Hong Kong 18
San Diego 18
Boulder 17
Grafing 17
Dakar 15
Izmir 15
Brussels 14
Bremen 13
Redwood City 13
Nanchang 11
Napoli 11
Los Angeles 10
Washington 10
Kunming 9
Lagos 9
Livorno 8
Shenyang 7
Tianjin 7
Boardman 6
Carrara 6
Changsha 6
Mumbai 6
Nürnberg 6
Hangzhou 5
Hebei 5
Jiaxing 5
Lucca 5
Massa Marittima 5
Scafati 5
Shanghai 5
Vicopisano 5
Amsterdam 4
Düsseldorf 4
Guangzhou 4
Hefei 4
Istanbul 4
Jinan 4
Lugo 4
Palermo 4
Pieve 4
San Francisco 4
Wuhan 4
Alassio 3
Bangalore 3
Bologna 3
Capannori 3
Cascina 3
Caserta 3
Castelliri 3
Centro 3
Grosseto 3
Massarosa 3
Montalto Di Castro 3
Norwalk 3
Ogden 3
Phoenix 3
Pontedera 3
Rochester 3
Sant'elpidio A Mare 3
Tekirdağ 3
Torino 3
Toronto 3
Venaria 3
Zhengzhou 3
Airola 2
Camaiore 2
Capannoli 2
Central 2
Ercolano 2
Totale 4.361
Nome #
Different patterns of H2S/NO activity and cross-talk in the control of the coronary vascular bed under normotensive or hypertensive conditions 216
Iminothioethers as Hydrogen Sulfide Donors: From the Gasotransmitter Release to the Vascular Effects 175
Hydrogen sulfide releasing capacity of natural isothiocyanates: is it a reliable explanation for the multiple biological effects of brassicaceae? 173
The novel H2S-donor 4-carboxyphenyl isothiocyanate promotes cardioprotective effects against ischemia/reperfusion injury through activation of mitoKATP channels and reduction of oxidative stress 168
Nuovi attivatori dell’enzima SIRT1 per il trattamento delle patologie cardiovascolari e cardiometaboliche 163
Association of KRAS mutations in cell-free circulating tumor DNA with occurrence of resistance to TKIs in NSCLC 157
1,2,4-Thiadiazolidin-3,5-diones as novel hydrogen sulfide donors 151
The Citrus Flavonoid Naringenin Protects the Myocardium from Ageing-Dependent Dysfunction: Potential Role of SIRT1 150
Arylthioamides as H2S Donors:l-Cysteine-Activated Releasing Properties and Vascular Effects in Vitro and in Vivo 148
Contribution of KRAS mutations and c.2369C > T (p.T790M) EGFR to acquired resistance to EGFR-TKIs in EGFR mutant NSCLC: a study on circulating tumor DNA 144
null 142
First examples of H2S-releasing glycoconjugates: stereoselective synthesis and anticancer activities 141
Memantine prodrug as a new agent for alzheimer’s disease 140
Anticancer properties of erucin, an H2S-releasing isothiocyanate, on human pancreatic adenocarcinoma cells (AsPC-1) 127
Pharmacological characterization of the vascular effects of aryl isothiocyanates: Is hydrogen sulfide the real player? 126
Impact of mucoadhesive polymeric nanoparticulate systems on oral bioavailability of a macromolecular model drug 117
null 113
DPYD and UGT1A1 genotyping to predict adverse events during first-line FOLFIRI or FOLFOXIRI plus bevacizumab in metastatic colorectal cancer 110
Mitochondriotropic and Cardioprotective Effects of Triphenylphosphonium-Conjugated Derivatives of the Diterpenoid Isosteviol 104
Design and synthesis of H2S-donor hybrids: A new treatment for Alzheimer's disease? 102
THIOAMIDE, IMINOTHIOETHER AND ISOTHIOCYANATE DERIVATIVES: CHEMOTYPES OF SLOW H2S-RELEASING AGENTS 100
null 100
Pharmacogenetics of CYP2D6 and tamoxifen therapy: Light at the end of the tunnel? 99
null 98
Anomalous Kv7 channel activity in human malignant hyperthermia syndrome unmasks a key role for H2S and persulfidation in skeletal muscle 96
KRAS mutations as potential mechanism of crizotinib acquired resistance: a study on circulating tumor DNA 95
Effect of glucoraphanin and sulforaphane against chemotherapy-induced neuropathic pain: Kv7 potassium channels modulation by H2S release in vivo 94
A Novel H2S-releasing Amino-Bisphosphonate which combines bone anti-catabolic and anabolic functions 93
null 92
Prodromal Intestinal Events in Alzheimer's Disease (AD): Colonic Dysmotility and Inflammation Are Associated with Enteric AD-Related Protein Deposition 91
The Renal Outer Medullary Potassium channel (ROMK): an intriguing pharmacological target for an innovative class of diuretic drugs 90
Erucin exhibits vasorelaxing effects and antihypertensive activity by H 2 S-releasing properties 90
Structure-activity relationships study of isothiocyanates for H2S releasing properties: 3-Pyridyl-isothiocyanate as a new promising cardioprotective agent 90
Anti-metastatic Properties of Naproxen-HBTA in a Murine Model of Cutaneous Melanoma 87
Ex vivo and in vivo study of sucrosomial® iron intestinal absorption and bioavailability 85
New activators of SIRT1 enzyme for the treatment of cardiovascular and cardiometabolic pathologies 81
Phosphorylation of AKT and ERK1/2 and mutations of PIK3CA and PTEN are predictive of breast cancer cell sensitivity to everolimus in vitro 80
Pathophysiological role of mitochondrial potassium channels and their modulation by drugs 76
The role of hydrogen sulfide and H2S-donors in myocardial protection against ischemia/reperfusion injury 75
Vascular effects of H2S-donors: Fluorimetric detection of H2S generation and ion channel activation in human aortic smooth muscle cells 72
KRAS has a role in acquired resistance to EGFR-TKIs in NSCLC: an analysis on circulating tumor DNA 69
D -Penicillamine modulates hydrogen sulfide (H2S) pathway through selective inhibition of cystathionine-γ-lyase 67
Anti-inflammatory and antiviral roles of hydrogen sulfide: Rationale for considering H2S donors in COVID-19 therapy 64
Mercaptopyruvate acts as endogenous vasodilator independently of 3-mercaptopyruvate sulfurtransferase activity 63
Iminothioethers As A Novel Class Of H2s-Donor: Gasotransmitter Release And Vascular Effects 62
5α-dihydrotestosterone abrogates sex bias in asthma like features in the mouse 61
null 60
Iminothioethers as a novel class of H2S-donor: gasotransmitter release and vascular effects 60
Role of hydrogen sulfide in endothelial dysfunction: Pathophysiology and therapeutic approaches 60
Organic Isothiocyanates as Hydrogen Sulfide Donors 59
Advances in Technologies for Highly Active Omega-3 Fatty Acids from Krill Oil: Clinical Applications 56
Development of In Vitro Corneal Models: Opportunity for Pharmacological Testing 55
Pharmacological evaluation of aryl-isothiocyanates as original H2S-donor derivatives: H2S-release and vascular effects 52
null 48
Early ctDNA dynamics as a surrogate for progression-free survival in advanced breast cancer in the BEECH trial 46
Hybrids between H2S-donors and betamethasone 17-valerate or triamcinolone acetonide inhibit mast cell degranulation and promote hyperpolarization of bronchial smooth muscle cells 43
Searching for novel hydrogen sulfide donors: The vascular effects of two thiourea derivatives 41
null 41
Natural organo-sulfur compounds inhibit RBL-2H3 mast cell degranulation 40
H2S donating corticosteroids: Design, synthesis and biological evaluation in a murine model of asthma 39
DPYD c.1905+1G>A and c.2846 A>T and UGT1A1*28 allelic variants as predictors of toxicity: Pharmacogenetic translational analysis from the phase III TRIBE study in metastatic colorectal cancer. 37
Role of hydrogen sulfide in cardiovascular ageing 36
The h2 s-donor erucin exhibits protective effects against vascular inflammation in human endothelial and smooth muscle cells 36
Recent efforts in drug discovery on vascular inflammation and consequent atherosclerosis 34
Cardiovascular benefits of Eruca sativa mill. Defatted seed meal extract: Potential role of hydrogen sulfide 33
Tumor suppressor role of hsa-mir-193a-3p and-5p in cutaneous melanoma 32
Contribution of KRAS mutations and c.2369C > T (p.T790M) EGFR to acquired resistance to EGFR-TKIs in EGFR mutant NSCLC: a study on circulating tumor DNA 29
Should CYP2D6 be genotyped when treating with tamoxifen? 29
Anti-Inflammatory Effect of the Natural H2S-Donor Erucin in Vascular Endothelium 25
Potential Effects of Natural H2 S-Donors in Hypertension Management 24
Sirtuin 1-Activating Compounds: Discovery of a Class of Thiazole-Based Derivatives 22
Regulation of blood pressure by natural sulfur compounds: Focus on their mechanisms of action 16
Influence of Polyphenols on Adipose Tissue: Sirtuins as Pivotal Players in the Browning Process 15
Should CYP2D6 be genotyped when treating with tamoxifen? [Letter in reply] 14
Design, Synthesis and Evaluation of Novel Molecular Hybrids between Antiglaucoma Drugs and H2S Donors 13
Hydrogen sulfide: The hidden player of isothiocyanates pharmacology 13
Pharmacological evaluation of innovative eye drop formulations containing TS-polysaccaride, hyaluronic acid and glycyrrhizin for irritative ocular diseases using in vitro reconstituted human corneal epithelium model 12
The novel H2S donor 4-carboxy-phenyl isothiocyanate inhibits mast cell degranulation and renin release by decreasing intracellular calcium 9
New Synthetic Analogues of Natural Polyphenols as Sirtuin 1-Activating Compounds 8
Anti-Inflammatory and Vasorelaxant Effects Induced by an Aqueous Aged Black Garlic Extract Supplemented with Vitamins D, C, and B12 on Cardiovascular System 8
Using hydrogen sulfide to design and develop drugs 6
New Visions on Natural Products and Cancer Therapy: Autophagy and Related Regulatory Pathways 5
Glucoraphanin Increases Intracellular Hydrogen Sulfide (H2S) Levels and Stimulates Osteogenic Differentiation in Human Mesenchymal Stromal Cell 3
Sirtuin 1-activating derivatives belonging to the anilinopyridine class displaying in vivo cardioprotective activities 2
Anti-Proliferative Properties of the Novel Hybrid Drug Met-ITC, Composed of the Native Drug Metformin with the Addition of an Isothiocyanate H2S Donor Moiety, in Different Cancer Cell Lines 2
Totale 6.200
Categoria #
all - tutte 16.328
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.328


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019314 0 0 0 0 0 0 0 0 0 81 126 107
2019/20201.372 120 93 182 89 111 137 154 115 127 98 108 38
2020/2021855 58 45 61 36 60 65 31 64 159 76 75 125
2021/2022771 23 24 17 22 126 135 25 34 47 39 67 212
2022/20231.272 149 179 98 80 125 162 12 80 245 15 74 53
2023/2024596 55 80 88 38 99 133 57 28 7 11 0 0
Totale 6.200